Increased Confidence in Deduplication of Drug Safety Reports with Natural Language Processing of Narratives at the US Food and Drug Administration

• Asıl Yazarlar: Kory Kreimeyer (Yazar), Oanh Dang (Yazar), Jonathan Spiker (Yazar), Paula Gish (Yazar), Jessica Weintraub (Yazar), Eileen Wu (Yazar), Robert Ball (Yazar), Taxiarchis Botsis (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The US Food and Drug Administration (FDA) receives millions of postmarket adverse event reports for drug and therapeutic biologic products every year. One of the most salient issues with these submissions is report duplication, where an adverse event experienced by one patient is reported multiple t...